T2 Biosystems
Developing a medical diagnostic platform that enables rapid and accurate diagnostic tests of all types on a single instrument.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | $8.0m | Private Placement VC |
| Total Funding | 000k | ||
Polaris Partners(exited)
In-Q-Tel(exited)
Aisling Capital(exited)
Goldman Sachs(exited)
CARB-X(exited)
Flybridge Capital Partners(exited)
Arcus Ventures(exited)
Camros Capital(exited)
Flagship Pioneering(exited)
Physic Ventures(exited)
WS Investments(exited)
Partners HealthCare(exited)
RA Capital Management(exited)
Aperture Venture Partners(exited)
Aperture Ventures Partners(exited)
Centre for Genomic Regulation(exited)
Noubar Afeyan(exited)
Noubar Afeyan(exited)
| USD | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 114 % | (20 %) | 125 % | 56 % | (21 %) | (67 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (1084 %) | (430 %) | (600 %) | (211 %) | (140 %) | (244 %) | (650 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (1338 %) | (510 %) | (738 %) | (261 %) | (175 %) | (286 %) | (696 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 509 % | 145 % | 204 % | 90 % | 78 % | 117 % | 197 % |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.